Sirtex Medical Ltd.

Sirtex Medical Ltd.
Stock Exchange Other OTC
EPS
$0.57
Market Cap
$1.31 B
Shares Outstanding
55.78 M
Public Float
-
Sirtex Medical Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.73
Market Cap
AUD1.85 B
Shares Outstanding
55.79 M
Public Float
49.96 M

Profile

Address
101 Miller Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.sirtex.com
Updated 09/14/2018
Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres. Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC.

Financials

View All

John Allan Eady
Chairman
Andrew McLean
Chief Executive Officer & Executive Director